Working to Eradicate Gynecologic Cancers

Claude A. Stringer, MD

MD
Texas Oncology, P.A.
3510 Worth St.
Dallas, TX
USA 75246

Papers:
1 Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: preliminary results